Composition comprising a biosurfactant and persicomycin

Abstract

The present invention relates to a composition comprising at least one biosurfactant and at least one persicomycin.

Description

Technical Field

[0001] The present invention relates to a composition comprising at least one biosurfactant and at least one persicomycin.

[0002] Prior Art Persicomycins are 3-(3’-hydroxy)hydroxy fatty acids and are a family of phytobacterial toxins. They are associated with necrosis in peach trees, and 3-(3’-hydroxydecanoyloxy)hexadecenoic acid is the most prominent persicomycin (see Eur J Biochem. 1996 Aug 1;239(3):702-9).

[0003] European Patent No. 2797571 discloses a composition comprising water, at least one biosurfactant and at least one fatty acid, wherein the total proportion of all surfactants in the composition is 1 to 30% by mass, and the proportion of the fatty acid is 0.1 to 20% by mass relative to the total of the fatty acid and the surfactant.

[0004] An object of the present invention is to provide a composition having excellent cleaning ability, particularly in household care applications.

[0005] Description of the Invention Surprisingly, it has been found that a composition comprising at least one biosurfactant and at least one persicomycin has special properties that make it well-suited for cleaning applications.

[0006] Accordingly, the present invention provides A) at least one biosurfactant, and B) at least one persicomycin in a composition.

[0007] The present invention further provides a method of cleaning an article as described in more detail in claim 9.

[0008] One advantage of the present invention is that the composition of the present invention has very good washing performance, especially in removing fatty stains from fabrics.

[0009] Another advantage of the present invention is that the composition of the present invention can be very easily rinsed from the washed surface, preferably from the fibers.

[0010] A further advantage is that the composition of the present invention supports the stability of enzymes with respect to storage.

[0011] One advantage of the present invention is that the composition of the present invention provides a pure biological detergent in which all components are of biological origin.

[0012] Another advantage of the present invention is that the composition of the present invention provides a detergent with a low total amount of surfactants while maintaining the cleaning ability.

[0013] Another advantage of the present invention is that the performance of the detergent, especially the performance against fatty stains, is improved.

[0014] A further advantage is that the composition of the present invention provides a high-performance detergent that uses fewer components. This significantly reduces the complexity of the formulation and results in a simpler manufacturing process.

[0015] Another advantage of the present invention is that the formulation exhibits particularly good emulsifying and dispersing properties.

[0016] Another advantage of the present invention is that the composition of the present invention provides a detergent that uses mild surfactants with low aquatic toxicity.

[0017] Another advantage of the present invention is that the composition of the present invention can be formulated to be 100% biodegradable.

[0018] Another advantage is that the formulation exhibits excellent compatibility with all the materials included in the washing machine with respect to corrosion.

[0019] Another advantage is that the formulation can be very easily diluted with water without the need for excessive agitation.

[0020] An advantage of the present invention is that the composition according to the present invention has a positive odor profile.

[0021] Another advantage of the present invention is that the composition according to the present invention has improved color stability. The color change reaction can result from the Maillard reaction, which is a chemical reaction between proteins or amino acids and sugars. Both of the reaction partners, the protein and the sugar, are typically contained in small amounts in fermentation-produced biosurfactants such as rhamnolipid, sophorolipid, or Rubiwettin. These low concentrations are sufficient to have a change from a light color to a dark color.

[0022] A further advantage is that the composition according to the present invention has improved surface cleaning properties.

[0023] Another advantage is that the composition according to the present invention has excellent foaming properties.

[0024] A further advantage is that the composition according to the present invention has reduced irritation to human skin.

[0025] Another advantage is that the composition according to the present invention is its mildness and good physiological compatibility, and is characterized in particular by high values in the red blood cell (RBC) test.

[0026] A further advantage is that the composition according to the present invention has a good feel during and after washing.

[0027] Another advantage is that the composition according to the present invention leaves a smooth and soft feel after washing.

[0028] Another advantage is that the composition according to the invention has a marked microbial stability.

[0029] Another advantage is that the composition according to the invention has an improved ability to dissolve oily substances and fats.

[0030] Another advantage is that the composition according to the invention has a higher viscosity than the corresponding composition without persicomycin.

[0031] The present invention relates to A) at least one biosurfactant, and B) at least one persicomycin, preferably 3-(3'-hydroxydecanoyloxy)hexadecenoic acid and provides a composition comprising the same.

[0032] Within the scope of the description of the present invention, "biosurfactant" is understood to mean all glycolipids produced by fermentation. The term "biosurfactant" also includes glycolipids that have been chemically or enzymatically modified after fermentation, as long as the structure of the glycolipid remains.

[0033] The raw materials for producing the biosurfactant that may be used are carbohydrates, especially sugars such as glucose, and / or lipophilic carbon sources such as fats, oils, partial glycerides, fatty acids, fatty alcohols, long-chain saturated or unsaturated hydrocarbons.

[0034] In the context of the description of the present invention, the term "surfactant" is understood to mean an organic substance having surfactant properties capable of reducing the surface tension of water to less than 45 mN / m at 20 °C and at a concentration of 0.5% by mass with respect to the total composition. The surface tension is measured at 20 °C by the Du Nouy ring method.

[0035] Within the scope of the description of the present invention, "persicomycin" is understood to mean 3-(3'-hydroxy)hydroxy fatty acids and their corresponding salts.

[0036] When the average value is described below, unless otherwise specified, these are the average values obtained by numerical averaging.

[0037] Unless otherwise specified, the percentages are data in mass percentage.

[0038] Unless otherwise specified, the measured values described below are measured at a temperature of 25°C and a pressure of 1013 mbar.

[0039] The composition according to the present invention preferably contains, as component A), at least one biosurfactant selected from rhamnolipid, sophorolipid, glucolipid, cellulose lipid, mannosylerythritol lipid and trehalose lipid, preferably rhamnolipid, sophorolipid and glucolipid, and most preferably rhamnolipid. The biosurfactant can be produced, for example, according to European Patent No. 0 499 434, US Patent No. 7,985,722, International Publication No. 03 / 006146, Japanese Unexamined Patent Application Publication No. 60-183032, German Patent Application Publication No. 19648439, German Patent Application Publication No. 19600743, Japanese Unexamined Patent Application Publication No. 01-304034, Chinese Patent Application Publication No. 1337439, Japanese Unexamined Patent Application Publication No. 2006-274233, Korean Patent Publication No. 2004-033376, Japanese Unexamined Patent Application Publication No. 2006-083238, Japanese Unexamined Patent Application Publication No. 2006-070231, International Publication No. 03 / 002700, French Patent Application Publication No. 2740779, German Patent Application Publication No. 2939519, US Patent No. 7,556,654, French Patent Application Publication No. 2855752, European Patent No. 1445302, Japanese Unexamined Patent Application Publication No. 2008-062179 and Japanese Unexamined Patent Application Publication No. 2007-181789, or the documents cited therein. Suitable biosurfactants can be obtained, for example, from Soliance (France).

[0040] Preferably, the composition according to the present invention has, as a biosurfactant, at least one selected from rhamnolipids, particularly monorhamnolipids, dirhamnolipids or polyrhamnolipids, glucolipids, particularly monoglucolipids, diglucolipids or polyglucolipids, and sophorolipids, particularly monosophorolipids, disophorolipids or polysophorolipids, preferably selected from rhamnolipids and glucolipids, and most preferably rhamnolipids.

[0041] The term "rhamnolipid" in the description of the present invention preferably refers to a specific compound of general formula (I) or a salt thereof

Chemical formula

[0042] When nRL is 1, the glycosidic bond between the two rhamnose units is preferably in the α-configuration. The active carbon atom of any fatty acid exists as the R-enantiomer (for example, (R)-3-{(R)-3-[2-O-(α-L-rhamnopyranosyl)-α-L-rhamnopyranosyl]oxydecanoyl}oxydecanoate).

[0043] In the description of the present invention, the term "diramunolipid" is understood to mean a compound of general formula (I) or a salt thereof in which nRL is 1 in the formula.

[0044] In the description of the present invention, the term "moniramunolipid" is understood to mean a compound of general formula (I) or a salt thereof in which nRL is 0 in the formula.

[0045] Separate ramunolipids are abbreviated according to the following nomenclature: "diRL-CXCY" in general formula (I) means that one of the R 1RL group and the R 2RL group is (CH2) o -CH3 [where o is X - 4], and the remaining R 1RL group or the R 2RL group is (CH2) o -CH3 [where o is Y - 4], which is understood to mean a diramunolipid of general formula (I). "monoRL-CXCY" in general formula (I) means that one of the R 1RL group and the R 2RL group is (CH2) o -CH3 [where o is X - 4], and the remaining R 1RL group or the R 2RL group is (CH2) o -CH3 [where o is Y - 4], which is understood to mean a moniramunolipid of general formula (I).

[0046] Therefore, the nomenclature used does not distinguish between "CXCY" and "CYCX".

[0047] For ramunolipids, when mRL is 0, monoRL-CX or diRL-CX is used accordingly.

[0048] When ":Z" is attached to one of the above indices X and / or Y, this means that the R 1RL group and / or the R 2RLIt means that each of the groups is equal to an unsubstituted, non-branched hydrocarbon group having X - 3 or Y - 3 carbon atoms each having Z double bonds.

[0049] Methods for producing related rhamnolipids are disclosed, for example, in European Patent Application Publication No. 2786743 and European Patent Application Publication No. 2787065.

[0050] Rhamnolipids applicable in the description of the present invention can also be produced, for example, by fermentation of Pseudomonas, preferably non-genetically engineered cells, especially Pseudomonas aeruginosa. This technique was already disclosed in the 1980s as recorded, for example, in European Patent Application Publication No. 0282942 and German Patent Application Publication No. 4127908. Rhamnolipids produced by Pseudomonas aeruginosa cells improved by genetic recombination to have a higher rhamnolipid titer can also be used in the description of the present invention, and such cells are disclosed, for example, by Lei et al. in Biotechnol Lett. 2020 Jun;42(6):997 - 1002.

[0051] Rhamnolipids produced by Pseudomonas aeruginosa are commercially available, for example, under the trademark Zonix from Jeneil Biotech Inc., under the trademark NatSurFact from Logos Technologies (acquired the technology by Stepan), under the trademark Rhapynal from Biotensidion GmbH, under the trademarks R90, R95, R95Md, R95Dd from AGAE technologies, from Locus Bio - Energy Solutions, and under the trademark Bio - 201 Glycolipids from Shanghai Yusheng Industry Co., Ltd.

[0052] The present invention is preferably a composition containing rhamnolipid as a biosurfactant, wherein the biosurfactant component A) is 51% to 100% by mass, preferably 60% to 95% by mass, particularly preferably 80% to 90% by mass of monorhamnolipid, especially the monorhamnolipid of formula (I) with nRL = 0 Here, the mass percentage indicates the total of all rhamnolipids present and provides a composition characterized by containing the same.

[0053] Surprisingly, this increases the viscosity of the composition according to the present invention. Preferably, this preferred embodiment is preferably combined with the content of a dirt remover of the carboxymethyl inulin type (see below).

[0054] The present invention further provides a composition preferably containing rhamnolipid as a biosurfactant, wherein the biosurfactant component A) is 51% to 95% by mass, preferably 55% to 80% by mass, particularly preferably 60% to 70% by mass of diRL-C10C10 Here, the mass percentage indicates the total of all rhamnolipids present and provides a composition characterized by containing the same.

[0055] A preferred composition according to the present invention is one in which the composition contains 0.5% to 15% by mass, preferably 3% to 12% by mass, particularly preferably 5% to 10% by mass of diRL-C10C12:1 Here, the mass percentage indicates the total of all rhamnolipids present and is characterized by containing the above-mentioned rhamnolipid in the content.

[0056] An even more preferred composition according to the present invention is one in which the composition contains 0.5 mass% to 25 mass%, preferably 3 mass% to 15 mass%, particularly preferably 5 mass% to 12 mass% of diRL-C10C12 Here, the mass percent indicates the total of all the rhamnolipids present and is characterized by containing the rhamnolipid described above in the content thereof.

[0057] A more preferred composition according to the present invention is a composition in which the composition contains, as a biosurfactant 0.1 mass% to 25 mass%, preferably 2 mass% to 10 mass%, particularly preferably 4 mass% to 8 mass% of diRL-C8C10 Here, the mass percent indicates the total of all the rhamnolipids present and is characterized by containing the rhamnolipid described above in the content thereof.

[0058] An even more preferred composition according to the present invention is a composition in which the composition contains 0.1 mass% to 5 mass%, preferably 0.5 mass% to 3 mass%, particularly preferably 0.5 mass% to 2 mass% of monoRL-C8C19, and / or, preferably and 0.1 mass% to 5 mass%, preferably 0.5 mass% to 3 mass%, particularly preferably 0.5 mass% to 2 mass% of monoRL-C10C10 Here, the mass percent indicates the total of all the rhamnolipids present and is characterized by containing the rhamnolipid described above in the content thereof.

[0059] The present invention alternatively provides a composition preferably containing rhamnolipid as a biosurfactant, wherein the biosurfactant component A) is 10 mass% to 50 mass%, preferably 20 mass% to 40 mass%, particularly preferably 25 mass% to 35 mass% of monoRL-C10C10 Here, the mass percent indicates the total of all the rhamnolipids present and is characterized by containing the same.

[0060] A preferred alternative composition according to the present invention preferably has a composition that, as a biosurfactant, contains 10% to 30% by mass, preferably 12% to 25% by mass, particularly preferably 15% to 20% by mass of di-RL-C10C10 where the mass percent indicates the total of all rhamnolipids present and is characterized by containing the above-described rhamnolipids in the content thereof.

[0061] A preferred alternative composition according to the present invention preferably has a composition that, as a biosurfactant, contains 10% to 30% by mass, preferably 12% to 25% by mass, particularly preferably 15% to 20% by mass of mono-RL-C8C10 where the mass percent indicates the total of all rhamnolipids present and is characterized by containing the above-described rhamnolipids in the content thereof.

[0062] A preferred alternative composition according to the present invention preferably has a composition that, as a biosurfactant, contains 3% to 25% by mass, preferably 5% to 20% by mass, particularly preferably 10% to 15% by mass of mono-RL-C10C12:1 where the mass percent indicates the total of all rhamnolipids present and is characterized by containing the above-described rhamnolipids in the content thereof.

[0063] A preferred alternative composition according to the present invention preferably has a composition that, as a biosurfactant, contains 1% to 15% by mass, preferably 2% to 10% by mass, particularly preferably 3% to 8% by mass of di-RL-C10C12 where the mass percent indicates the total of all rhamnolipids present and is characterized by containing the above-described rhamnolipids in the content thereof.

[0064] The production methods of related rhamnolipids are disclosed, for example, in European Patent Application Publication No. 2786743 and European Patent Application Publication No. 2787065.

[0065] The rhamnolipids applicable in the description of the present invention can also be preferably produced by the fermentation of Pseudomonas, which are cells not genetically modified, especially Pseudomonas aeruginosa. This technology was already disclosed in the 1980s, as recorded, for example, in European Patent Application Publication No. 0282942 and German Patent Application Publication No. 4127908. Rhamnolipids produced by Pseudomonas aeruginosa cells improved to have a high rhamnolipid titer by genetic recombination can also be used in the description of the present invention, and such cells are disclosed, for example, by Lei et al. in Biotechnol Lett. 2020 Jun;42(6):997-1002.

[0066] The rhamnolipids produced by Pseudomonas aeruginosa are commercially available from Jeneil Biotech Inc. under the trade name Zonix, from Logos Technologies (acquired the technology by Stepan) under the trade name NatSurFact, from Biotensidion GmbH under the trade name Rhapynal, from AGAE technologies under the trade names R90, R95, R95Md, R95Dd, from Locus Bio-Energy Solutions, and from Shanghai Yusheng Industry Co., Ltd. under the trade name Bio-201 Glycolipids.

[0067] In the description of the present invention, the term "sophorolipid" preferably refers to the compounds of general formulas (IIa) and (IIb) and their salts

Chemical formula

[0068] Sophorolipids may be used according to the invention in their acid form or in their lactone form.

[0069] Preferred compositions according to the invention contain sophorolipids in which the mass ratio of the lactone form to the acid form is in the range from 20:80 to 80:20, particularly preferably in the range from 30:70 to 40:60.

[0070] The determination of the content of sophorolipids in the acid or lactone form in the formulation is shown in European Patent No. 1411111, page 8, paragraph No.

[0053] .

[0071] In connection with the present invention, the term "glucolipid" preferably refers to compounds of general formula (III) and their salts

Chemical formula

[0072] Separate glycolipids are abbreviated according to the following nomenclature: “GL-CXCY” in the general formula (III), R 1GL group and R 2GL group are (CH2) o -CH3 [wherein o is X - 4], and the remaining R 1GL group or R 2GL group are (CH2) o -CH3 [wherein o is Y - 4], and is understood to mean a glycolipid of the general formula (III).

[0073] Therefore, the nomenclature used does not distinguish between “CXCY” and “CYCX”.

[0074] When one of the indices X and / or Y is provided as “:Z”, this means that each of the groups R 1GL and / or R 2GL is an unbranched, unsubstituted hydrocarbon group having X - 3 or Y - 3 carbon atoms having Z double bonds.

[0075] The method for producing a glycolipid can be carried out as described in International Publication No. WO 2019 / 154970.

[0076] A preferred composition according to the present invention has a ratio of component B) to component A) in the range of 1:2000 to 1:3, preferably 1:1000 to 1:10, more preferably 1:300 to 1:20, and most preferably 1:100 to 1:25.

[0077] When determining the contents of components A) and B) in the description of the present invention, the mass in a form that is not a salt is considered, and thus the mass of the corresponding cation is ignored.

[0078] Preferred compositions according to the present invention further C) at least one enzyme, preferably at least one enzyme selected from the group consisting of protease, amylase, lipase, pectinase, cellulase, phosphodiesterase, mannanase, cutinase, pectate lyase, peroxidase, oxidase and laccase comprise.

[0079] Enzymes are useful additives in laundry compositions. Enzymes preferably contained in the compositions according to the present invention are selected from the group consisting of protease, amylase, lipase, pectinase, cellulase, phosphodiesterase, mannanase, cutinase, pectate lyase, peroxidase, oxidase and laccase, and protease, amylase, lipase, pectinase, cellulase, phosphodiesterase and mannanase are particularly preferred.

[0080] The enzymes to be used in the description of the present invention may, for example, be derived from microorganisms such as the genus Bacillus, Streptomyces, Humicola or Pseudomonas, and / or may be produced by suitable microorganisms according to known biotechnological methods, such as transgenic expression hosts such as the genus Escherichia, Bacillus or filamentous fungi.

[0081] In particular, it may be a technical enzyme preparation of each enzyme, that is, it is important that accompanying substances may be present. Thus, the enzyme can be packaged and used together with accompanying substances, for example, from fermentation or from other stabilizers.

[0082] Suitable proteases include those derived from bacteria, fungi, plants, viruses or animals, such as those derived from plants or microorganisms. Those derived from microorganisms are preferred. Chemically modified or protein-modified variants are included. It may be an alkaline protease, such as a serine protease or a metalloprotease. The serine protease may be, for example, from the S1 family, such as trypsin, or from the S8 family, such as subtilisin. The metalloprotease may be, for example, thermolysin from family M4, or other metalloproteases, such as metalloproteases from families M5, M7 or M8.

[0083] Examples of proteases are subtilisin BPN from Bacillus amyloliquefaciens, carlsberg from Bacillus licheniformis, protease PB92, subtilisins 147 and 309, protease from Bacillus lentus, subtilisin DY and subtilase (although no longer assigned to subtilisin in the narrow sense), thermitase, proteinase K, protease TW3 and TW7.

[0084] Subtilisin carlsberg is sold in a further developed form under the trade name Alcalase® by Novozymes A / S (Bagsværd, Denmark).

[0085] Subtilisins 147 and 309 are sold by Novozymes under the trade names Esperase® and Savinase®, respectively. The protease variant under the name BLAP® is derived from a protease from Bacillus lentus DSM 5483. Further proteases that can be used are, for example, those belonging to the trade names Durazym®, Relase®, Everlase®, Nafizym®, Natalase®, Kannase®, and Ovozyme® manufactured by Novozymes, Purafect®, Purafect® OxP, Purafect® Prime, Excellase®, and Properase® manufactured by Danisco / Genencor, those managed under the trade name Protosol® manufactured by Company Advanced Biochemicals Ltd. (Thane, India), those managed under the trade name Wuxi® manufactured by Wuxi Snyder Bioproducts Ltd. (China), those managed under the trade names Proleather® and Protease P® manufactured by Amano Pharmaceuticals Ltd. (Nagoya, Japan), and those managed under the trade name Proteinase K-16 manufactured by Kao Corp. (Tokyo, Japan).

[0086] Proteases derived from Bacillus gibsonii and Bacillus pumilus disclosed in International Publication No. WO 08 / 086916 and International Publication No. WO 07 / 131656, which are international patent applications, are also particularly preferably used.

[0087] More advantageously usable proteases are disclosed in the patent applications International Publication No. WO 91 / 02792, International Publication No. WO 08 / 007319, International Publication No. WO 93 / 18140, International Publication No. WO 01 / 44452, UK Patent Application Publication No. 1243784, International Publication No. WO 96 / 34946, International Publication No. WO 02 / 029024, and International Publication No. WO 03 / 057246. Other proteases that can be used are those found in the microorganism Stenotrophomonas maltophilia, in particular Stenotrophomonas maltophilia K279a, Bacillus intermedius, and Bacillus sphaericus, which occur naturally.

[0088] Other commercially available proteases are Liquanase® EC 3.5 L, Liquanase® Evity® EC 3.5 L, Liquanase® 3.5 L, Liquanase® Evity® 3.5 L, Preferenz P100, Preferenz P200, Preferenz P300, Biotouch ROC, BIOPROTEASA L 800 ST, Bioproteasa 800 P, Bioproteasa L 800, Lavergy® Pro 114 LS, Progress Uno EC 100 L, Progress Uno 100 L, Progress Uno 101 L, EFFECTENZ TM P 100(A01339), EFFECTENZ TMP 150, Savinase® Evity® EC 16 L, Savinase® Evity® EC 24 T, Savinase® Evity® 16 L, Savinase® Evity® 24 T, Excellenz P 1250, Blaze® Evity® EC 150 T, Blaze® Evity® 150 T, Blaze® Evity® 125 T, Blaze Evity 16 L, Excellase, Purafect, Purafect OxP, Purafect Prime, Properase, Blaze® Pro EC 100 L, Blaze® Pro 100 L, Blaze Exceed 100 T, Progress Key 150 T, Progress Excel 101 L.

[0089] The protease preferably included in the composition according to the present invention is Liquanase® 2.5 L.

[0090] Suitable amylases that can be used herein are alpha - amylase or glucoamylase, which may be derived from bacteria or fungi. Chemically modified or protein - modified mutants are included. The amylase includes, for example, an alpha - amylase obtained from a special strain of Bacillus, for example, Bacillus licheniformis as described in detail in UK Patent Application Publication No. 1,296,839.

[0091] Examples of amylases are α - amylases from Bacillus licheniformis, Bacillus amyloliquefaciens or Bacillus stearothermophilus, especially their further improved developed products for use in detergents or cleaning agents.

[0092] The enzyme from Bacillus licheniformis is available from Novozymes under the name Termamyl® and from Danisco / Genencor under the name Purastar® ST.

[0093] Further developed products of this α - amylase are available from Novozymes under the trade names Duramyl® and Termamyl® ultra, from Danisco / Genencor under the trade name Purastar® OxAm, and from Daiwa Seiko Inc. (Tokyo, Japan) under the trade name Keistase®.

[0094] The α - amylase from Bacillus amyloliquefaciens is sold by Novozymes under the name BAN®, and variants from the α - amylase from Bacillus stearothermophilus are also sold by Novozymes under the names BSG® and Novamyl®.

[0095] Furthermore, the α - amylase from Bacillus species A 7 - 7 (DSM 12368) and the cyclodextrin glucanotransferase (CGTase) from Bacillus agaradherens (DSM 9948) should also be emphasized.

[0096] The amylose-degrading enzymes disclosed in International Publication Nos. WO 03 / 002711, WO 03 / 054177, and WO 07 / 079938, which are international patent applications, can also be used.

[0097] Fusion products of all the molecules mentioned can also be used. Furthermore, further developed products of α-amylase derived from Aspergillus niger and Aspergillus oryzae, which are available from Novozymes under the trade name Fungamyl®, are also suitable. Further commercially available products that can be advantageously used are, for example, Amylase-LT®, Stainzyme®, Stainzyme ultra®, or Stainzyme plus®, all of which are manufactured by Novozymes. Variants of these enzymes obtained by point mutations can also be used according to the present invention.

[0098] Other commercially available amylases are Amplify Prime EC 110 L, Amplify Prime 100 L, PREFERENZ S 110, Bioamyl P, Stainzyme Plus Evity, Stainzyme® Plus Evity® EC 12 T, Stainzyme® Plus Evity® EC 24 T, Stainzyme® Plus Evity® 24 T, EFFECTENZ TM S 100, EFFECTENZ TM S210, Bialfa T, Achieve Alpha EC 110 L, Achieve Alpha 100 L, Achieve® Advance 150 T, Stainzyme, Amplify, Duramyl, Novamyl.

[0099] Amplify TM Prime 100 L is preferably a composition according to the present invention.

[0100] Suitable cellulases include those derived from bacteria or fungi. Chemically modified or protein-modified variants are included. Suitable cellulases include cellulases from the genera Bacillus, Pseudomonas, Humicola, Fusarium, Thielavia, Acremonium, such as the fungal cellulases produced from Humicola insolens, Myceliophthora thermophila, and Fusarium oxysporum, as disclosed in U.S. Patent Nos. 4,435,307, 5,648,263, 5,691,178, 5,776,757, and International Publication No. 89 / 09259.

[0101] An example of a cellulase (endoglucanase, EG) is a cellulase preparation rich in fungal endoglucanase (EG) or a further developed product thereof, which is provided by Novozymes under the trade name Celluzyme®.

[0102] The products Endolase® and Carezyme®, also available from Novozymes, are based on 50kD-EG or 43kD-EG from Humicola insolens DSM 1800. Other commercially available products from this company that can be used are Cellusoft®, Renozyme®, and Celluclean®. Cellulases, such as those based on 20kD EG at least partially from Melanocarpus spp., available from AB Enzymes (Finland) under the trade names Ecostone® and Biotouch®, can also be used. Other cellulases from AB Enzymes are Econase® and Ecopulp®. Further suitable cellulases are those from Bacillus spp. CBS 670.93 and CBS 669.93, and Bacillus spp. CBS 670.93 is available from Danisco / Genencor under the trade name Puradax®.

[0103] Other commercially available products from Danisco / Genencor that can be used are "Genencor detergent cellulase L" and IndiAge® Neutra.

[0104] Other commercially available cellulases are Carezyme® Premium EC 4510 L, Carezyme® Premium Evity® EC 5000 T, Carezyme® Premium 4500 L, Carezyme® Premium Evity® 5000 T, REVILATENZ 200, Biotouch DCL / FCL, Biosoft L Pure, Rocksoft, Retrocell, Retrocell ZircoN, Puradax EG 7000L, Biotouch FCC, BIOCELULASA MC L, BIOCELULASA MC P, Celluclean® EC 5000 L, Celluclean® 5000 L, REVILATENZ 200, Biotouch FLX, Lavergy® C Bright 100 L, Celluclean® Evity® EC 4500 T, Celluclean® Evity® 4500 T, Biotouch DCC.

[0105] Even more preferred enzymes present in the compositions of the present invention are enzymes known by the term glycosidase (E.C. 3.2.1.X). These include, in particular, arabinase, fucosidase, galactosidase, galactanase, arabicogalactan galactosidase, mannanase (also called mannosidase or mannanase), glucuronidase, agarase, carrageenase, pullulanase, β-glucosidase, xyloglucanase (xylanase), xantanase and pectinolytic enzymes.

[0106] Preferred glycosidases are also grouped under the term hemicellulase. Hemicellulase includes, in particular, mannanase, xyloglucanase (xylanase), β-glucosidase and carrageenase, as well as pectinase, pullulanase and β-glucanase. Pectinase is a pectin-degrading enzyme, in particular a hydrolytic pectin-degrading enzyme belonging to the enzyme classes EC 3.1.1.11, EC 3.2.1.15, EC 3.2.1.67 and EC 3.2.1.82. In the context of the present invention, pectinase includes pectin lyase, pectin esterase, pectin demethoxylase, pectin methoxylase, pectin methyl esterase, pectase, pectin methyl esterase, pectinoesterase, pectin-galacto-lactase, pectin-galacto-galactase, pectin-galacto-galactase, pectin-galacto-galactase, pectin-galacto-galactase, pectin-galacto-galactase, pectin-galacto-galactase, pectin-galactase, endopolygalacturonase, pectin-poly-galactase, pectin-polyhydrolase, pectin-poly-galactase, pectin-polyhydrolase, pectin-poly-galactase, pectin-poly-galactase, pectin-poly-galactase-a-1,4-galacturonide glycanohydrolase, endogalacturonase, endo-D-galacturonase, galacturan 1,4-a-galacturonidase, exopolygalacturonase, poly(galacturonic acid) hydrolase, exo-D-galacturonase, exo-D-galacturonanase-galacturonase, exo-poly-α-galacturonosidase, exopolygalacturonosidase or exopolygalacturanosidase.

[0107] Examples of suitable enzymes in this regard are, for example, those named Gamanase®, Pektinex AR® or Pectaway® manufactured by Novozymes, Rohapec® B1 L manufactured by AB Enzymes, and Pyrolase® manufactured by Diversa Corp. (San Diego, CA, USA).

[0108] β-glucanase obtained from Bacillus subtilis is available from Novozymes under the name Cereflo®.

[0109] A particularly preferred glycosidase or hemicellulase according to the present invention is mannanase, which is available, for example, from Novozymes under the trade name Mannaway® or from Danisco / Genencor under the trade name Purabrite®.

[0110] Examples of commercially available mannanases are Mannaway® EC 200 L, Mannaway® EC 108 L, Mannaway® 200 L, Mannaway® 100 L, PREFERENZ M100, Biotouch M, Biomananasa 2XL.

[0111] The mannanase preferably contained in the composition according to the present invention is Mannaway® 4.0 L.

[0112] Examples of commercially available pectate lyases are Xpect® EC 1000 L, Xpect® EC 1000 T, Xpect® 1000 L, Xpect® 1000 T, PREVERENZ F 1000, Pectex Pure, Lavergy® Pro 106 L, Lavergy® Pro 106 LS.

[0113] Examples of commercially available licheninases are Lift INTENT 100 L, Lift INTENT 100 T.

[0114] Suitable lipases and cutinases include those derived from bacteria or fungi. Chemically modified or mutant enzymes with modified proteins are included. Examples of lipases or cutinases were originally from Humicola lanuginose (Thermomyces lanuginosus), those obtained therefrom or further developed, especially those having the amino acid substitution D96L. These are sold, for example, by Novozymes under the trade names Lipolase®, Lipolase® Ultra, LipoPrime®, Lipozyme® and Lipex®.

[0115] Other lipases that can be advantageously used are available from Novozymes under the trade name Lipoclean®.

[0116] Furthermore, for example, cutinases originally isolated from Fusarium solani pisi and Humicola insolens can be used. Lipases that may be used are available from Amano under the names Lipase CE®, Lipase P®, Lipase B®, or Lipase CES®, Lipase AKG®, Bacillis sp. Lipase®, Lipase AP®, Lipase M-AP®, and Lipase AML®. For example, lipases or cutinases from Danisco / Genencor originally isolated from Pseudomonas mendocina and Fusarium solanii can be used as the starting enzyme. Other important commercially available products are the preparations M1 Lipase® and Lipomax® originally sold by Gist-Brocades (now Danisco / Genencor), and Lipase MY-30®, Lipase OF®, Lipase PL®, and the Danisco / Genencor product Lumafast® from Meito Sangyo KK (Japan).

[0117] Other commercially available lipases are Lipex® Evity® EC 100 L, Lipex® Evity® EC 100 T, Lipex® Evity® EC 200 L, Lipex® Evity® 100 L, Lipex® Evity® 100 T, Lipex® Evity® 200 L, PREFERENZ L 100, Biolipasa 2XL, Biolipasa L, Biolipasa P, Lipoclean, Lipolase, Lipolase Ultra.

[0118] The lipase preferably contained in the composition according to the present invention is Lipex TM 100 L Evity

[0119] An example of a commercially available phosphodiesterase is Pristine manufactured by Novozymes

[0120] Suitable peroxidases / oxidases include those derived from plants, bacteria or fungi. Chemically modified or protein-modified mutants are included. Examples of useful peroxidases include peroxidases derived from the genus Coprinus, such as Coprinus cinereus, and their variants described in WO 93 / 24618, WO 95 / 10602, and WO 98 / 15257

[0121] A commercially available peroxidase is Guardzyme TM (Novozymes A / S)

[0122] A preferred composition according to the present invention contains the sum of A) and B) in an amount of 2.0% to 60% by mass, preferably 5.0% to 40% by mass, more preferably 10.0% to 30% by mass, and optionally contains C) in an amount of 0.2% to 10% by mass, preferably 1.0% to 8.0% by mass, more preferably 1.5% to 6.0% by mass wherein the mass percentages relate to the total composition

[0123] A preferred composition according to the present invention is characterized by containing at least one non-biosurfactant preferably selected from the group of anionic, cationic, non-ionic, semi-polar, amphoteric and zwitterionic surfactants

[0124] Preferred non-biosurfactants are selected from the group of fatty alcohol alkoxylates

[0125] These can be advantageously used for cleaning the surface of fabrics or cloths containing polyamines.

[0126] Non-limiting examples of anionic surfactants include sulfates and sulfonates, especially linear alkylbenzene sulfonates (LAS), isomers of LAS, branched alkylbenzene sulfonates (BABS), phenylalkane sulfonates, α-olefin sulfonates (AOS), olefin sulfonates, alkene sulfonates, alkane-2,3-diyl bis(sulfates), hydroxyalkane sulfonates and disulfonates, alkyl sulfates (AS) such as sodium dodecyl sulfate (SDS), fatty alcohol sulfates (FAS), primary alcohol sulfates (PAS), alcohol ether sulfates (AES or AEOS or FES, also called alcohol ethoxysulfates or fatty alcohol ether sulfates), secondary alkane sulfonates (SAS), paraffin sulfonates (PS), ester sulfonates, sulfonated fatty acid glycerol esters, α-sulfo fatty acid methyl esters (α-SFMe or SES) including methyl ester sulfonates (MES), alkyl or alkenyl succinic acids, dodecenyl / tetradecenyl succinic acid (DTSA), fatty acid derivatives of amino acids, sulfosuccinic acids or diesters and monoesters of soaps, and combinations thereof.

[0127] Non-limiting examples of cationic surfactants include alkyldimethyl ethanolamine quats (ADMEAQ), cetyltrimethylammonium bromide (CTAB), dimethyldistearylammonium chloride (DSDMAC), alkylbenzyl dimethylammonium, alkyl quaternary ammonium compounds, alkoxylated quaternary ammonium (AQA) compounds, and combinations thereof.

[0128] Non-limiting examples of nonionic surfactants include alcohol ethoxylates (AE or AEO), preferably included in the compositions according to the invention, alcohol propoxylates, propoxylated fatty alcohols (PFA), alkoxylated fatty acid alkyl esters, such as ethoxylated and / or propoxylated fatty acid alkyl esters, alkylphenol ethoxylates (APE), nonylphenol ethoxylates (NPE), alkyl polyglycosides (APG), alkoxylated amines, fatty acid monoethanolamides (FAM), fatty acid diethanolamides (FADA), ethoxylated fatty acid monoethanolamides (EFAM), polyglycerol esters, glycerol esters, propoxylated fatty acid monoethanolamides (PFAM), polyhydroxyalkyl fatty acid amides, or N-acyl N-alkyl derivatives of glucosamine (glucamides, GA, or fatty acid glucamides, FAGA), and products available under the trade names SPAN and TWEEN, and combinations thereof.

[0129] Non-limiting examples of semi-polar surfactants include amine oxides (AO), such as alkyldimethylamine oxides, N-(cocoalkyl)-N,N-dimethylamine oxide and N-(tallowalkyl)-N,N-bis(2-hydroxyethyl)amine oxide, fatty acid alkanolamides, ethoxylated fatty acid alkanolamides, and combinations thereof.

[0130] Non-limiting examples of amphoteric and zwitterionic surfactants include betaines, alkyldimethylbetaines, sulfobetaines, hydroxysultaines, and combinations thereof.

[0131] Furthermore, bio-based surfactants not based on glycolipids, such as lipopeptides like surfactin or phospholipids like lecithin, may be included in the compositions according to the invention.

[0132] The composition according to the present invention may further comprise one or more adjuvants selected from the group consisting of a bleaching system, a hydrotrope, a polymer (which may be synthetic), a biopolymer, an anti-redeposition agent, a fiber protectant, a soil release agent, a dye transfer inhibitor, a fabric color regulator, an opacifier, a blue dye, an enzyme stabilizer, a solvent, a viscosity modifier, a preservative, a pH adjuster, and salts such as NaCl and Na2SO4.

[0133] Any polymer known in the art for use in detergents may be utilized. The polymer may function as a cobuilder as described above, or may provide anti-redeposition, fiber protection, soil release, dye transfer inhibition, viscosity modification, grease cleaning and / or defoaming properties. Exemplary polymers include (carboxymethyl) cellulose (CMC), poly(vinyl alcohol) (PVA), poly(vinyl pyrrolidone) (PVP), poly(ethylene glycol) or poly(ethylene oxide) (PEG), ethoxylated poly(ethyleneimine), carboxymethyl inulin (CMI), and polycarboxylates such as PAA, PAA / PMA, polyaspartic acid, and lauryl methacrylate / acrylic acid copolymer, hydrophobically modified CMC (HM-CMC) and silicone, copolymers of terephthalic acid and oligomeric glycol, copolymers of poly(ethylene terephthalate) and poly(oxyethene terephthalate) (PET-POET), PVP, poly(vinyl imidazole) (PVI), poly(vinyl pyridine-N-oxide) (PVPO or PVPNO) and polyvinyl pyrrolidone-vinyl imidazole (PVPVI). Further exemplary polymers include sulfonated polycarboxylates, polyethylene oxide and polypropylene oxide (PEO-PPO), and dicquaternary ethoxysulfate. Other exemplary polymers are disclosed in International Publication No. WO 2006 / 130575. Salts of the above polymers are also contemplated.

[0134] The preferred composition according to the present invention is characterized by containing at least one selected from an anti-redeposition polymer and a soil release polymer, and the soil release polymer is preferred. This has a technical effect of further enhancing the cleaning ability of the composition according to the present invention. In combination with glycolipids having one sugar ring in the molecule, such as monorhamnolipids and the glycolipids of formula (III), a surprising increase in viscosity can be observed.

[0135] In the description of the present invention, the anti-redeposition polymer or the soil release polymer is selected from the group consisting of modified cellulose, preferably carboxymethyl cellulose, cellulose acetate and methyl cellulose, modified starch, modified inulin, preferably carboxymethyl inulin, polyitaconic acid, polyvinylpyrrolidone, polyvinyl alcohol, and polyethylene glycol, and carboxymethyl cellulose and methyl cellulose are most preferred.

[0136] More preferred soil release polymers are, for example, water-soluble polyesters in the range of TexCare® commercially available under the names TexCare SRN 260, TexCare SRN 170, TexCare SRN 170 Terra, TexCare SRN 260 SG Terra, TexCare SRN 260 Life, and combinations thereof, and soil release polymers disclosed in European Patent Application Publication No. 3218461, European Patent Application Publication No. 3218465, European Patent Application Publication No. 3489340, and European Patent Application Publication No. 3489338.

[0137] More preferred soil release polymers are selected from carboxymethyl inulin. A commercial example is Carboxyline® CMI.

[0138] This type of soil release polymer is particularly useful for promoting an increase in viscosity caused by elements of glycolipids having one sugar ring in the molecule, such as monorhamnolipids and the glycolipids of formula (III).

[0139] European Patent Application Publication No. 1746109 discloses a hybrid polymer of amylose and acrylate, which can also be advantageously used as a soil removal polymer in the composition of the present invention. A commercially available example of this type of soil removal polymer is Alcoguard® H 5941.

[0140] Non-limiting examples of biopolymers include starch, such as corn starch, maize starch and tapioca starch, modified starch, such as starch hydroxypropyltrimonium chloride and hydrolyzed corn starch, cellulose, bacterial cellulose, modified cellulose, such as microcrystalline cellulose, hydroxypropylmethyl cellulose and cetyl hydroxyethyl cellulose, guar gum, pectin, inulin, carrageenan, alginate, galactomannan, polycitronellol, carboxymethyl inulin, carboxymethyl cellulose, polyitaconic acid, and combinations and salts thereof.

[0141] Suitable non-aqueous solvents include monohydric or polyhydric alcohols, alkanolamines, or glycol ethers, provided that they are miscible with water within a defined concentration range.

[0142] The solvent is preferably selected from ethanol, n-propanol, i-propanol, butanol, glycol, propanediol, butanediol, glycerin, diglycol, propyl diglycol, butyl diglycol, hexylene glycol, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol propyl ether, n-butyl glycol ether, ethylene glycol monoglycol ether, diethylene glycol ethyl ether, propylene glycol methyl ether, propylene glycol ethyl ether, propylene glycol propyl ether, dipropylene glycol monomethyl ether, dipropylene glycol monoethyl ether, diisopropylene glycol monomethyl ether, diisopropylene glycol monoethyl ether, methoxytriglycol, ethoxytriglycol, butoxytriglycol, 1-butoxyethoxy-2-propanol, n-butoxyethoxy-2-propanol, di-butoxyethoxy-2-propanol, 3-butyl-3-methoxy ether solvent, and mixtures of these solvents, butoxyethoxy-2-propanol, 3-butyl-3-butyl ether, propyl glycol, dioctanol ether, dibutoxy-2-propanol, 3-butyl-3-butyl ether, propanol, propylene glycol, dibutoxyethoxy-2-propanol, dibutoxyethoxy-2-propanol, 3-butoxy-3-methoxy ether solvent, diisopropylene glycol monomethyl ether, diisopropylene glycol monomethyl ether, and mixtures of these solvents.

[0143] However, the surfactant preparation preferably contains a polyol as a non-aqueous solvent. The polyol may include glycerol, 1,2-propanediol, 1,3-propanediol, ethylene glycol, diethylene glycol and / or dipropylene glycol.

[0144] Any preservative known in the art for use in detergents may be used. Examples of preservatives include phenoxyethanol, sodium levulinate, sodium benzoate, p-anisic acid, potassium sorbate, benzoic acid, glyceryl caprylate, caprylyl glycol, pentylene glycol, methylpropanediol, bronopol, isothiazolinones (methylisothiazolinone, chloromethylisothiazolinone), and combinations thereof.

[0145] Preferably, the composition according to the invention comprises one or more encapsulated substances containing a benefit agent, preferably a sensory benefit agent. Preferred encapsulated substances in the present description include shear / pressure-sensitive encapsulated substances, whereby the sensory benefit agent is released in response to mechanical forces (e.g., friction, pressure, shear stress) on the encapsulated substance. The encapsulation shell is preferably composed of materials including, but not limited to, polyurethane, polyamide, polyolefin, polysaccharide, protein, silicone, lipid, modified cellulose, gum, polyacrylate, polyphosphoric acid, polystyrene, polyester, or combinations of these materials.

[0146] Preferably, the sensory benefit agent may include a skin benefit agent or an olfactory benefit agent and / or be a volatile benefit agent. The sensory benefit agent may also be beneficial to hair and / or a hard surface and / or a fabric. The sensory benefit agent may have defoaming properties and be advantageously encapsulated so as not to prevent foaming until released by rubbing. Suitable volatile benefit agents include, but are not limited to, fragrances, insect repellents, essential oils, sensory agents such as menthol, and aromatherapy actives, preferably fragrances. Mixtures of volatile benefit agents may also be used. The total amount of the benefit agent is preferably 0.01 to 10% by mass, more preferably 0.05 to 5% by mass, even more preferably 0.1 to 4.0% by mass, and most preferably 0.15 to 4.0% by mass based on the total mass of the composition. A preferred benefit agent is a fragrance. The composition of the present invention may contain a non-encapsulated (also referred to as non-capsulated) volatile benefit agent. When the volatile benefit agent is a fragrance, the fragrances described below are suitable for use as encapsulated volatile benefit agents and as non-encapsulated fragrance components.

[0147] Preferably, the composition according to the present invention has a viscosity in the range of 5 to 400 mPas, preferably 10 to 350 mPas, preferably 15 to 300 mPas (measurement: Brookfield LV, s61, 200 rpm, 20 °C). Preferably, the composition of the present invention has a turbidity of 0.005 to 5000, preferably 1.0 to 100 nephelometric turbidity units. The turbidity measurement is carried out with a 2100Q Portable Turbidimeter that measures the intensity of light scattered at 90 degrees when a light beam passes through a liquid sample and directly responds in NTU. NTU is a unit for measuring the low transparency of a liquid and is used, for example, in water treatment plants and sewage treatment plants and in ocean research. For example, water containing 1 milligram of fine silica per liter has a turbidity of 1 NTU. The water to be measured is placed in a standard container. The light beam passes through the water and hits a sensor on the opposite side of the container. A second sensor is installed at a right angle to the light beam to measure the light scattered by the particles in the water. The turbidity in NTU can be calculated from the ratio of the light intensities of the two sensors.

[0148] The compositions contemplated herein are preferably detergent compositions. These may be in any convenient form, such as bars, homogeneous tablets, tablets having two or more layers, pouches having one or more compartments, conventional powders, compact powders, granules, pastes, gels, conventional liquids, compact liquids or concentrated liquids. There are a number of forms of detergent formulations, such as layers (same or different phases), pouches, and mechanical dosing units.

[0149] The pouch can be configured as a single or multiple compartments. The pouch can be of any form, shape, and material suitable for holding the composition, for example, the composition is not allowed to be released from the pouch before contacting with water. The pouch is made of a water-soluble film that surrounds the internal volume. The internal volume can be divided into compartments of the pouch. Preferred films are polymers, preferably polymers formed into films or sheets. Preferred polymers, copolymers, or their derivatives are selected from polyacrylates, and water-soluble acrylate copolymers, methylcellulose, carboxymethylcellulose, sodium dextrin, ethylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, maltodextrin, polymethacrylate, most preferably polyvinyl alcohol copolymer and hydroxypropylmethylcellulose (HPMC). Preferably, the concentration of the polymer in the film, such as PVA, is at least about 60%. The preferred average molecular weight is typically about 20,000 to about 150,000. The film can be a hydrolyzable and water-soluble polymer blend, such as polylactic acid and polyvinyl alcohol (known by the trademark M8630 sold by Chris Craft In.Prod.Of Gary Ind.(US)), and a plasticizer, such as glycerol, ethylene glycol, propylene glycol, sorbitol, and mixtures thereof. The pouch may contain a solid laundry detergent composition or a partial component thereof, and / or a liquid cleaning composition or a partial component thereof, separated by a water-soluble film. The compartments for the liquid components may have a different composition from the compartments containing solids, for example, see U.S. Patent Application Publication No. 20090011970.

[0150] The detergent components may be physically separated by compartments in the water-soluble pouch or tablets of different layers. Thereby, the adverse storage interactions between the components can be avoided. The different dissolution profiles of each compartment may delay the dissolution of the selected components in the cleaning solution.

[0151] The detergent composition according to the present invention is in the form of a laundry soap bar and may be used for hand - washing laundry, fabrics and / or textiles. The term laundry soap bar includes laundry bars, soap bars, combo bars, synthetic detergent bars and detergent bars. The types of bars usually differ in the type of surfactant they contain, and the term laundry soap bar includes those containing soap derived from fatty acids and / or synthetic soap. The laundry soap bar is solid at room temperature and has a physical form that is not liquid, gel or powder. The term solid is defined as a physical form that does not change significantly over time, i.e., when a solid object (e.g., a laundry soap bar) is placed in a container, the solid object does not change to fill the container. The bar is typically a solid in the shape of a bar, but may be other solid shapes, such as circular or oval.

[0152] The detergent composition according to the present invention may be formulated as a granular suspension as described in WO 09 / 092699, EP 1705241 A1, EP 1382668 A1, WO 07 / 001262, US 6,472,364, WO 04 / 074419 or WO 09 / 102854.

[0153] The detergent composition according to the present invention is preferably in the form of a liquid or gel detergent. This may be aqueous and typically contains at least 20% by mass of water, this percentage being relative to the total composition. Other types of liquids including, but not limited to, alkanols, amines, diols, ethers and polyols may be included in the aqueous liquid or gel. The aqueous liquid or gel detergent composition may contain 0 - 30% by mass of an organic solvent, this percentage being relative to the total composition. The liquid or gel detergent may be non - aqueous.

[0154] A preferred composition according to the present invention is characterized in that the pH of the composition at 25°C is 3.0 - 10.0, preferably 4.0 - 9.5, and particularly preferably 7.0 - 9.0.

[0155] Unless otherwise specified, the "pH" related to the present invention is defined as the value measured for the relevant composition at 25°C after stirring for 5 minutes using a pH electrode calibrated in accordance with ISO 4316 (1977).

[0156] The present invention further provides a method for cleaning the surface of an article, preferably a fabric or a textile, comprising the following steps: a) preparing the composition according to the present invention and the article; b) combining the prepared composition and the prepared article with water; c) maintaining the temperature of the water containing the prepared composition and the prepared article in the range of 15°C to 100°C, preferably 25°C to 65°C, more preferably 35°C to 45°C, for a period of 5 minutes to 240 minutes, preferably 10 minutes to 180 minutes, more preferably 20 minutes to 120 minutes, while temporarily moving the prepared article in the water; d) separating the article from the water, and optionally e) rinsing the article further with water A method comprising the above steps is provided.

[0157] A preferred method according to the present invention is characterized in that the mass ratio of the article and water prepared in steps b) and c) is in the range of 1:2 to 1:30, preferably 1:3 to 1:25, more preferably 1:4 to 1:20.

[0158] A preferred method according to the present invention is characterized in that in step b), 0.1 g to 50 g, preferably 1.0 g to 20 g, more preferably 2.0 g to 10 g of the composition according to the present invention is provided per 1 kg of water.

[0159] The present invention further provides the use of the composition according to the present invention for cleaning the surface of an article, preferably a fabric or a textile.

[0160] Preferably, the use according to the present invention is characterized by removing fat and / or oil, preferably solid fat stains, from the surface of the article.

[0161] The examples presented below describe the present invention by way of example and are not intended to limit the present invention in any way, and the present invention is not limited to the embodiments specified in the examples from the entire specification and claims.

[0162] Example: The rhamnolipid used was prepared as described in Example 1 of European Patent Application Publication No. 3061442, and the rhamnolipid is similar to dirhamnolipid. The monorhamnolipid was prepared as described in Example 2 of European Patent Application Publication No. 3061442.

[0163] The sophorolipid used was Sophorolipid REWOFERM SL ONE manufactured by Evonoik, where the ratio of lactone to acid is 40:60.

[0164] The glucolipid was prepared by fermentation according to Example 2 of International Publication No. 2019154970.

[0165] Example 1: The following formulations were prepared. Here, the numerical values are the mass percentages of the active substances. Benchmark 1 and Benchmark 2 (commercially available detergents), and Benchmark 3, Benchmark 4, and Benchmark 5 (detergents available within the company) do not conform to the present invention, and Detergents 1 to 6 are according to the present invention. [Table 1] [Table 2] [Table 3] [Table 4-1] [Table 4-2] [Table 5]

Table 6

Table 7

[0166] For the evaluation of the compositions in Table 1 and Table 2, a stain removal test was carried out using a Linitest apparatus.

[0167] The Linitest apparatus was used for the test.

Table 8

Table 9

[0168] The stains used were purchased from CFT (Vlaardingen, Netherlands), which is also recommended by A.I.S.E (Laundry Detergent Testing Guidelines).

[0169] After washing, the fabric was rinsed and air-dried.

[0170] The degree of stain removal was evaluated by measuring the reflectance with a spectrophotometer and using the Y value of the Y, x, y color coordinate measurement and a D65 light source with a 420 nm UV cut-off filter. The aperture used for the actual stains was 15 mm (minimum 12 mm). The measurement was carried out with the stain spread out, and for each stain, it was measured 3 times (at the center of the circular area or the nearest homogeneous area), so 18 times for each stain. For each stain, measurements were taken before washing (to confirm the quality of the stain) and after washing, and the standard deviation was evaluated and reported.

[0171] The results are presented as the average of the values of Y between three repetitions and its standard deviation (σ), and are shown in Tables 8 to 14. The better the stain removal, the larger the Y value.

Table 10

Table 11

Table 12

Table 13

Table 14

Table 15

Table 16

Table 17

[0172] Evaluation of results: Surprisingly, it has been found that the addition of the persicomycin component to the biosurfactant-based detergent formulation results in good washing performance with respect to soil removal. Particularly in the case of fatty soils, this combination was superior in performance to both the persicomycin-free formulations (Benchmarks 3, 4 and 5) and the commercially available formulations (Benchmarks 1 and 2). Furthermore, the addition of persicomycin increases the viscosity of the overall formulation, which very well meets the market and consumer expectations for liquid laundry detergents.

[0173] Examples of other detergents

Table 18

[0174]

Table 19

[0175]

Table 20

[0176]

Table 21

[0177]

Table 22

[0178]

Table 23

[0179]

Table 24

[0180]

Table 25

[0181]

Table 26

[0182]

Table 27

[0183]

Table 28

[0184]

Table 29

[0185]

Table 30

[0186]

Table 31

[0187]

Table 32

[0188]

Table 33

[0189]

Table 34

[0190]

Table 35

[0191]

Table 36

[0192]

Table 37

[0193]

Table 38

[0194]

Table 39

[0195]

Table 40

[0196]

Table 41

[0197]

Table 42

[0198]

Table 43

[0199]

Table 44

[0200]

Table 45

[0201]

Table 46

[0202]

Table 47

[0203]

Table 48

[0204]

Table 49

[0205]

Table 50

[0206]

Table 51

[0207]

Table 52

[0208]

Table 53

[0209]

Table 54

[0210]

Table 55

[0211]

Table 56

[0212]

Table 57

[0213]

Table 58

[0214]

Table 59

[0215]

Table 60

[0216]

Table 61

[0217]

Table 62

[0218]

Table 63

[0219]

Table 64

[0220]

Table 65

[0221]

Table 66

[0222]

Table 67

[0223]

Table 68

[0224]

Table 69

[0225]

Table 70

[0226]

Table 71

[0227]

Table 72

[0228]

Table 73

[0229]

Table 74

[0230]

Table 75

[0231]

Table 76

[0232]

Table 77

[0233]

Table 78

[0234]

Table 79

[0235]

Table 80

[0236]

Table 81

[0237]

Table 82

[0238]

Table 83

[0239]

Table 84

[0240]

Table 85

[0241]

Table 86

[0242]

Table 87

[0243]

Table 88

[0244]

Table 89

[0245]

Table 90

[0246]

Table 91

[0247]

Table 92

[0248]

Table 93

[0249]

Table 94

[0250]

Table 95

[0251]

Table 96

[0252]

Table 97

[0253]

Table 98

[0254]

Table 99

[0255]

Table 100

[0256]

Table 101

[0257]

Table 102

[0258]

Table 103

[0259]

Table 104

[0260]

Table 105

[0261]

Table 106

[0262]

Table 107

[0263]

Table 108

[0264]

Table 109

[0265]

Table 110

[0266]

Table 111

[0267]

Table 112

Claims

1. The following, A) at least one biosurfactant, and B) at least one persicomycin A composition comprising.

2. The composition according to claim 1, wherein the biosurfactant is selected from rhamnolipid, glucolipid, sophorolipid, preferably rhamnolipid and glucolipid, and most preferably rhamnolipid.

3. The composition according to claim 1 or 2, wherein the ratio of component B) to component A) is in the range of 1:2000 to 1:3, preferably 1:1000 to 1:10, more preferably 1:300 to 1:20, and most preferably 1:100 to 1:

25.

4. The following, C) at least one enzyme, preferably at least one enzyme selected from the group consisting of protease, amylase, lipase, pectinase, cellulase, phosphodiesterase, mannanase, cutinase, pectate lyase, peroxidase, oxidase and laccase The composition according to any one of claims 1 to 3, characterized by comprising.

5. The following, The total of A) and B) is in an amount of 2.0% to 60% by mass, preferably 5.0% to 40% by mass, more preferably 10.0% to 30% by mass, and optionally C) is in an amount of 0.2% to 10% by mass, preferably 1.0% to 8.0% by mass, more preferably 1.5% to 6.0% by mass, The composition according to any one of claims 1 to 4, characterized by containing (wherein the mass percentage relates to the total composition).

6. The composition according to any one of claims 1 to 5, characterized by comprising at least one non-biosurfactant, preferably at least one non-biosurfactant selected from the group of anionic, cationic, non-ionic, semi-polar, amphoteric and zwitterionic surfactants.

7. The composition according to any one of claims 1 to 6, characterized by comprising at least one selected from an anti-redeposition polymer and a soil removal polymer.

8. The composition according to claim 7, characterized in that the anti-redeposition polymer or the soil release polymer is selected from the group consisting of modified cellulose, preferably carboxymethyl cellulose, cellulose acetate and methyl cellulose, modified starch, modified inulin, preferably carboxymethyl inulin, polyitaconic acid, polyvinylpyrrolidone, polyvinyl alcohol, and polyethylene glycol.

9. A method for cleaning the surface of an article, preferably a fabric or a textile, comprising the following steps: a) preparing the composition according to any one of claims 1 to 8 and the article; b) combining the prepared composition and the prepared article with water; c) maintaining the temperature of the water containing the prepared composition and the prepared article in the range of 15 °C to 100 °C, preferably 25 °C to 65 °C, more preferably 35 °C to 45 °C for a period of 5 minutes to 240 minutes, preferably 10 minutes to 180 minutes, more preferably 20 minutes to 120 minutes, while temporarily moving the prepared article in the water; d) separating the article from the water, and optionally e) rinsing the article further with water. The method as described above.

10. The method according to claim 9, characterized in that the mass ratio of the article and water prepared in steps b) and c) is in the range of 1:2 to 1:30, preferably 1:3 to 1:25, more preferably 1:4 to 1:

20.

11. The method according to claim 9 or 10, characterized in that in step b), 0.1 g to 50 g, preferably 1.0 g to 20 g, more preferably 2.0 g to 10 g of the composition according to any one of claims 1 to 8 is provided per 1 kg of water.

12. Use of the composition according to any one of claims 1 to 8 for cleaning the surface of an article, preferably a fabric or a textile.

13. Use according to claim 12, characterized in that fat and / or oil is removed from the surface of the article.

Images